BlackRock’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $111M | Buy |
|
|||||
|
2025
Q1 | $138M | Sell |
|
|||||
|
2024
Q4 | $207M | Buy |
|
|||||
|
2024
Q3 | $179M | Buy |
|
|||||
|
2024
Q2 | $222M | Buy |
|
|||||
|
2024
Q1 | $323M | Buy |
|
|||||
|
2023
Q4 | $322M | Buy |
|
|||||
|
2023
Q3 | $201M | Sell |
|
|||||
|
2023
Q2 | $524M | Sell |
|
|||||
|
2023
Q1 | $505M | Sell |
|
|||||
|
2022
Q4 | $398M | Buy |
|
|||||
|
2022
Q3 | $484M | Buy |
|
|||||
|
2022
Q2 | $307M | Buy |
|
|||||
|
2022
Q1 | $301M | Buy |
|
|||||
|
2021
Q4 | $277M | Buy |
|
|||||
|
2021
Q3 | $180M | Sell |
|
|||||
|
2021
Q2 | $358M | Sell |
|
|||||
|
2021
Q1 | $253M | Sell |
|
|||||
|
2020
Q4 | $344M | Buy |
|
|||||
|
2020
Q3 | $180M | Sell |
|
|||||
|
2020
Q2 | $202M | Buy |
|
|||||
|
2020
Q1 | $156M | Buy |
|
|||||
|
2019
Q4 | $146M | Buy |
|
|||||
|
2019
Q3 | $113M | Buy |
|
|||||
|
2019
Q2 | $114M | Buy |
|
|||||
|
2019
Q1 | $72.6M | Sell |
|
|||||
|
2018
Q4 | $49.2M | Buy |
|
|||||
|
2018
Q3 | $50.7M | Buy |
|
|||||
|
2018
Q2 | $61.6M | Buy |
|
|||||
|
2018
Q1 | $24.5M | Buy |
|
|||||
|
2017
Q4 | $21.1M | Buy |
|